Brentuximab Intravenous and Prolixin

• Generic Name: brentuximab
• Dosage Forms: n.a.
• Other Brand Names: Adcetris

Brentuximab injection is used to treat Hodgkin lymphoma, systemic anaplastic large cell lymphoma (sALCL), and primary cutaneous anaplastic large cell lymphoma (pcALCL), which are blood cancers. It is given to patients who have received a bone marrow (autologous stem cell) transplant or other cancer treatments that did not work well.

Brentuximab injection is also used together with other cancer medicines to treat a previously untreated stage III or IV classical Hodgkin lymphoma.

Brentuximab interferes with the growth of cancer cells, which are then destroyed by the body.

Brentuximab is to be given only by or under the direct supervision of your doctor.

• Generic Name: fluphenazine
• Dosage Forms: Tablets USP and Elixir USP
• Other Brand Names: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate

Prolia (denosumab) is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.

The Prolia brand of denosumab is used to treat osteoporosis in postmenopausal women who have high risk of bone fracture.

Prolia is used to increase bone mass in men with osteoporosis with a high risk of bone fracture, and in women and men with a high risk of bone fracture caused by receiving treatments for certain types of cancer.

Prolia is also used to treat glucocorticoid-induced osteoporosis in men and women at high risk of bone fracture.